Biofabricated tissues have found numerous applications in tissue engineering and
regenerative medicine in addition to the promotion of disease modeling and drug …

Despite all the advances in preventing, diagnosing, and treating cardiovascular disorders,
they still account for a significant part of mortality and morbidity worldwide. The advent of …

ABSTRACT 3D printing technologies are emerging as a disruptive innovation for the
treatment of patients in cardiac failure. The ability to create custom devices, at the point of …

Hypoplastic left heart syndrome (HLHS) is a complex congenital heart condition in which a
neonate is born with an underdeveloped left ventricle and associated structures. Without …

The ability to modulate the mechanical properties, and cell alignment within a cardiac patch
without hindering cell functionality may have significant impact on developing therapies for …

Congestive heart failure (CHF) is a complicated pathophysiological syndrome, leading
cause of hospitalization as well as mortalities in developed countries wherein an irregular …

Background Patients with end-stage heart failure must receive treatment to recover cardiac
function, and the current primary therapy, heart transplantation, is plagued by the limited …

This review article will cover the recent developments in the new evolving field of Purkinje
bioengineering and the development of human Purkinje networks. Recent work has …

The field of biological pumps is a subset of cardiac tissue engineering and focused on the
development of tubular grafts that are designed generate intraluminal pressure. In the …

The field of ventricle tissue engineering is focused on bioengineering highly functioning left
ventricles that can be used as model systems for basic cardiology research and for …